Head-to-Head

Bio-Rad Laboratories, Inc.Class A vs. Harvard Bioscience Inc

BIO

Bio-Rad Laboratories, Inc.Class A

$390.34 +2.25%

VS HBIO

Harvard Bioscience Inc

$7.58 +0.40%

Bio-Rad Laboratories, Inc.Class A (BIO) comes out ahead, leading on 7 of 8 compared factors.

Size & Scale

BIOHBIO
Market Cap $10.44 billion $34.37 million
Revenue (TTM) $2.59 billion $87.81 million
Net Income (TTM) $222.40 million $-10,412,000

BIO leads on 3 of 3 size & scale factors.

Valuation

BIOHBIO
P/E Ratio 47.54 —
Price / Book 1.45 4.63
Price / Sales 4.03 0.39

BIO and HBIO split the valuation factors evenly.

Profitability

BIOHBIO
Net Margin 8.59% -11.86%
Return on Equity 3.10% -140.36%

BIO leads on 2 of 2 profitability factors.

Risk & Sentiment

BIOHBIO
Short Interest 2.44% 11.71%

BIO leads on 1 of 1 risk & sentiment factors.

Dig deeper: BIO overview, BIO financials, HBIO overview, HBIO financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.